EXHIBIT 10.13

                             DISTRIBUTION AGREEMENT


THIS DISTRIBUTION AGREEMENT (this "Agreement") is made as of April 16, 2004;
BETWEEN: Possis Medical, Inc., a Minnesota corporation, 9055 Evergreen Boulevard
NW, Minneapolis, Minnesota 55433 ("Distributor" or "Possis");

AND: Angiometrx Inc., a corporation incorporated under the Canada Business
Corporations Act and having its primary business office at Unit 107, 1099 8th
Avenue West, in the City of Vancouver, in the Province of British Columbia,
Canada; ("Manufacturer" or "Angiometrx")

BACKGROUND

A. Angiometrx manufactures (or causes to be manufactured) and markets certain
products and devices described in the attached Exhibit A (such products and
devices are referred to as the "Products");

B. Distributor possesses the facilities, personnel, ability and capacity to
promote the sale and use of the Products in the geographic area described in the
attached Exhibit B (such area is referred to as the "Territory"); and

C. Angiometrx wishes to sell the Products to Distributor, and Distributor wishes
to purchase the Products for resale in the Territory.

AGREEMENT

In consideration of the foregoing and of the mutual covenants contained herein,
and intending to be legally bound, Angiometrx and Distributor agree as follows:

1.       DISTRIBUTION.

a.)      APPOINTMENT. Subject to the terms of this agreement, Angiometrx hereby
         appoints Distributor and Distributor hereby accepts appointment as the
         exclusive distributor of Products in the Territory.

b.)      DURATION AND TERMINATION.

         (1)      This Agreement shall begin on the date written above and shall
                  continue in full force and effect for a three and one quarter
                  year term, expiring August 1, 2007. The Agreement can be
                  extended up to an additional twenty-four (24) months by
                  agreement in writing between Angiometrx and Distributor,
                  provided Angiometrx and Distributor can negotiate agreeable
                  sales volume commitments and contract duration for the
                  extended term. These negotiations may begin anytime and must
                  be concluded by the thirty third (33) month of the original
                  term.

         (2)      Each of the following circumstances shall constitute an "Event
                  of Default" under this Agreement: i) Material breach of any
                  term or condition of this Agreement; ii) The repeated failure
                  of a party to perform one or more of its obligations whether
                  or not this repeated failure constitutes a material breach;
                  iii) The filing by or against the other party of any
                  insolvency or bankruptcy proceeding, or proceedings for
                  reorganization, receivership, dissolution or any arrangement
                  under bankruptcy law, iv) The existence of a condition of
                  force majeure for longer than six (6) months; v) Any change in
                  a party's ownership which shall impair its ability to perform
                  its obligations under this Agreement; or vi) The failure or
                  inability of Distributor to meet sales objectives outlined in
                  Section 2(d)(2).

         Upon the occurrence of an Event of Default by one of the parties, the
         other party may terminate this Agreement upon thirty (30) days prior
         written notice to the defaulting party; provided that the defaulting
         party shall not have cured the default within such thirty (30) day
         period. Therefore, if the Event of Default is not cured within that
         thirty (30) day period, this Agreement will be deemed terminated. Not
         withstanding the foregoing, no notice shall be required for an Event of
         Default as defined in Section 1(b)(2)(iii).


                                       49
<PAGE>

         (3) During the 30 day notice period described in subsection (2) above,
         the party giving notice may withhold its own performance (except with
         respect to payment of any amount then due and owed to the other party)
         unless the other party cures or acts with due diligence to cure the
         Event of Default within the notice period.

     c.) SUB-DISTRIBUTORS.

         If at any time during the term of this Agreement Distributor appoints
         any sub-distributors for the Products, Distributor shall:

         i)       Cause such sub-distributors to comply fully with all
                  obligations imposed hereunder upon Distributor applicable to
                  resale of the Products within the Territory;

         ii)      Obtain a guarantee from any such sub-distributor that it will
                  not represent itself as an employee, agent or representative
                  of Angiometrx;

         iii)     Indemnify Angiometrx and defend and hold Angiometrx harmless
                  from all claims, damages and liabilities which Angiometrx may
                  incur in connection with the appointment or termination of
                  such sub-distributor and the sale of Products by such
                  sub-distributor; iv) Submit to Angiometrx a list of the
                  sub-distributors including addresses, fax and phone numbers.

     d.) CONFLICTS OF LNTEREST.

         In the absence of approval by the Manufacturer, such approval not to be
         unreasonably withheld, Distributor expressly agrees not to engage in
         any activity relating to a product that competes directly with the
         Products. These competing products are outlined in Exhibit E

     e.) INDEPENDENT CONTRACTOR.

         Distributor is an independent contractor authorized only to purchase
         products from Angiometrx for resale within the Territory. Nothing in
         this Agreement creates a relationship of employer-employee,
         principal-agent, franchiser-franchisee, joint venture or partnership
         between Distributor and Angiometrx. Distributor has no power or
         authority to bind Angiometrx in any way for any purpose, nor to give
         any representation on Angiometrx's behalf, nor to create any liability
         against Angiometrx. Distributor agrees to indemnify and to hold
         harmless Angiometrx from and against any and all claims, damages or
         liabilities arising from any act of Distributor outside of its scope of
         authority under this Agreement.


2. PRODUCTS.

     a.) PRICE.
         (1) The initial Price for the Products is set forth in the attached
         Exhibit C. Said prices shall be binding on Manufacturer for the first
         year of the term of this Agreement and shall be modified only with the
         express approval of Distributor, except as noted in section 2.a.(2).

         (2) Prices may be modified by the Manufacturer for the second year of
         the Agreement upon 60 days notice to Distributor, provided that
         AngioMetrx demonstrates that the price change is justified by an
         increase to Angiometrx of at least ten per cent (10%) in the
         manufacturing costs for the Products ( inclusive of the impact of
         changes in the applicable currency exchange rate). Following such a
         price increase, the new price shall be fixed for the entire year.
         Prices may be modified by the Manufacturer for the third year of the
         Agreement upon the same terms and conditions as required for a price
         increase in the second year of the Agreement.

         (3) Any modified price will not apply to orders received and accepted
         by Angiometrx prior to the effective date of such Distributor price
         changes.

         (4) All prices and shipments to Distributor shall be F.O.B.
         Angiometrx's plant in Vancouver, Canada. To such prices shall be added
         all shipment costs, transit insurance costs, and applicable duties or
         taxes and other related costs and expenses relating to the sale and
         shipment of the Products to Distributor. The Manufacturer shall ship
         all Products to the Distributor's main facility located in Minnesota,
         or such other location as may be designated from time to time by the
         Distributor. The Distributor shall specify its carrier of choice for
         shipments in each purchase order to the Manufacturer. The Manufacturer
         will invoice the Distributor for any shipment costs incurred.


                                       50
<PAGE>

     b.) PURCHASE ORDERS.

         (1) Distributor agrees to purchase the Products from Angiometrx, solely
         from Angiometrx and not from any other source, and Distributor agrees
         that purchase of the Products is for resale on Distributor's own
         account.

         (2) Distributor may issue only written purchase orders for the Products
         to Angiometrx. All purchase orders shall specify Product type,
         quantity, desired shipping date, unit price (from the Price List),
         unique purchase order number, shipping destination and any special
         shipping instructions. All purchase orders shall be subject to the
         terms and conditions of this Agreement and in the event of a conflict
         or inconsistency between the terms of this Agreement and the terms of
         any purchase order or other document submitted by Distributor to
         Angiometrx, this Agreement shall control unless the parties
         specifically otherwise agree in writing.

         (3) Angiometrx may impose, as a prerequisite to its acceptance of a
         purchase order, the payment of outstanding delinquent invoices.

         (4) Angiometrx will acknowledge the acceptance of a purchase order by a
         written order confirmation, shipment of the Products ordered, or other
         appropriate communication. Distributor acknowledges and understands
         that Angiometrx's obligation to sell any Products is subject to
         availability of Products. No purchase order shall be binding upon
         Angiometrx until the same is accepted in writing by Angiometrx.

         (5) Angiometrx shall make reasonable efforts to fill each purchase
         order that is accepted, but Angiometrx shall not be liable for damages
         caused by failure to ship or delay in shipment resulting from
         conditions beyond the control of Angiometrx, including but not limited
         to the inability of its suppliers to obtain material and supplies or to
         produce sufficient components to meet Product sales demand. Any failure
         by Angiometrx to ship Product ordered by Distributor to meet the
         minimum purchase requirements as provided in Exhibit D herein shall
         reduce Distributor's purchase requirements provided in Exhibit D herein
         for that period and shall suspend the remedies provided in Section
         (d)(2) herein for Distributor's failure to meet purchase requirements
         during that period.

     c.) PAYMENT.

         (1) All amounts due to Angiometrx shall be for the net invoice amount
         paid in U.S. Dollars without discount or rebate. Payment terms are
         thirty (30) days, which shall be stated on each invoice. Angiometrx may
         at its sole discretion require wire transfer prior to shipment or
         irrevocable standby letter of credit payable by sight draft from
         Distributor. If Distributor is prohibited from making payment in U.S.
         Dollars because of any applicable law or regulation, Angiometrx may
         elect to designate a currency or mode of payment not so prohibited, or
         to terminate this Agreement upon ten (10) days written notice.
         Termination does not discharge any obligation of Distributor to
         promptly pay any unpaid invoices in full in any non-prohibited currency
         designated by Angiometrx.

         (2) If Distributor is delinquent in remitting payments to Angiometrx
         under the terms of any invoice, Angiometrx may: i) decline to accept
         new purchase orders; ii) charge Distributor interest on past due
         amounts at a rate of 1.5 percent per calendar month; and/or iii)
         require advance payment, payment on delivery, or bank-guaranteed method
         of payment for further shipments. Distributor shall comply with the
         modified payment terms. The foregoing remedies of Angiometrx are not
         exclusive, but in addition to any and all remedies available to
         Angiometrx under this Agreement and applicable law.




     d.) SALES.

         (1) Distributor shall restrict to the Territory its active promotion
         and marketing of the Products. Distributor shall not actively pursue
         sales of the Products outside the Territory.

         (2) Minimum purchase requirements are as set out in Exhibit D. Failure
         of Distributor in any one-year period to purchase the annual commitment
         shall result in a ninety (90) day probationary period. During this
         period, Distributor must increase purchases to levels specified by
         Angiometrx. If Distributor fails to meet the probationary purchase
         requirements, Angiometrx may terminate this Agreement immediately upon
         written notice to Distributor.

         (3) Distributor shall submit detailed sales and inventory reports to
         Angiometrx on a quarterly basis, together with a rolling good faith but
         non-binding sales forecast. The reports shall be in a form and
         substance as reasonably required by Angiometrx.


                                       51
<PAGE>

     e.) SHIPMENT, DELIVERY AND INVENTORY.

         (1) All risk of loss or damage to the Products shipped will pass from
         Angiometrx to Distributor at the time the shipment is delivered to the
         carrier.

         (2) Delivery schedules set forth in Angiometrx's order confirmations
         reflect Angiometrx's reasonable estimate of actual shipping dates.
         Angiometrx will use its reasonable best efforts to meet such dates.
         Partial shipments will constitute independent transactions for which
         payment is due according to the terms of this Agreement. Distributor
         shall be solely responsible for obtaining whatever licenses, permits or
         the like may be required to allow it to receive the Product.

         (3) Distributor shall inspect the Products promptly upon their arrival
         at their shipping destination. All defects or other nonconformities of
         the Products to the terms of the purchase order discoverable upon
         receiving inspection, must be reported in writing to Angiometrx within
         thirty (30) days after the date of receipt of the Products, or
         Distributor's rights for redress shall be forever waived. All other
         defects or nonconformities must be reported in writing within thirty
         (30) days after discovery or Distributor's rights for redress shall be
         forever waived.

         (4) Distributor shall at all times maintain sufficient inventory of
         Products to meet customer demand and established sales objectives for
         the Territory.

         (5) Shelf Life Conditions and Remedies:

         i)       NINE MONTHS OR GREATER SHELF LIFE: For any product that is
                  provided to the Distributor with a minimum of nine (9) months
                  shelf life, the Distributor may not return inventory to
                  Angiometrx or transfer inventory to any other distributor
                  without Angiometrx's express written consent. Product can be
                  returned to Angiometrx only in the event of termination of
                  this distribution agreement subject to the following
                  limitations: Product with a minimum of six (6) months shelf
                  life remaining can be returned for a refund of the purchase
                  price; Product with less than six (6) months remaining shelf
                  life cannot be returned; Distributor will bear all risks of
                  loss or damage to returned Products occurring before receipt
                  of the Products by Angiometrx.

         ii)      LESS THAN NINE MONTHS SHELF LIFE: For any Product that is
                  provided to the Distributor with less than nine (9) months
                  shelf life, the Distributor can return it to the Manufacturer
                  at any time for full refund or replacement. Distributor will
                  bear all risks of loss or damage to returned Products
                  occurring before receipt of the Products by Angiometrx.


         (6) Notwithstanding the provisions of Section 2(e)(5) herein,
         Manufacturer shall accept the return and issue full credit to
         Distributor for all product returned by Distributor, unless
         Manufacturer can demonstrate such returned product is functional and
         shows no operational defect. Manufacture shall issue a credit of $75.00
         to Distributor for all product returned by Distributor as to which
         Manufacturer can demonstrate the absence of any functional or
         operational defect.


     f.) PRODUCT MODIFICATIONS.

         (1)      Angiometrx reserves the right to modify the design,
                  specifications, and/or the method of manufacture of the
                  Products at any time and to substitute the modified Products
                  for those originally ordered by Distributor, provided there is
                  no material alteration of the Products' form, fit, function or
                  quality and Distributor is provided notice of such
                  modifications prior to the delivery of any Product to
                  Distributor. Angiometrx may not discontinue manufacture of the
                  Products without reasonable notice to Distributor.

         (2)      Manufacturer shall provide, at its cost, all software upgrades
                  deemed beneficial to the performance of the Metricath 1000
                  Console; such software upgrades shall be installed as the
                  parties shall mutually agree.

3. DISTRIBUTOR'S OBLIGATIONS.

     In addition to Distributor's other agreements herein, Distributor further
agrees to:

         a.)      Exercise its best efforts to (1) promote the sale of the
                  Products at its own expense throughout the Territory using
                  such means as advertising, customer contact, distribution of
                  printed materials, attendance at trade shows and conventions,
                  support of local surgeons at trade shows and conventions and
                  the like; (2) promote the goodwill of Angiometrx; and (3) meet
                  or exceed the sales objectives established in Section 2;

                                       52
<PAGE>

         b.)      Provide and maintain at its own expense, one or more suitable
                  places of business in the Territory staffed with an adequate
                  force of competent sales personnel who are thoroughly familiar
                  with the Products and shall contact customers throughout the
                  Territory; pay all expenses incurred by its personnel relating
                  to attendance at Angiometrx's training or other presentations
                  regarding the Products; c.) Cooperate with Angiometrx in the
                  sponsorship and planning of technical seminars on the
                  Products, without charge to Angiometrx; d.) Furnish without
                  charge to Angiometrx market surveys and related information
                  prepared by Distributor or third parties pertaining to the
                  market for the Products in the Territory; e.) Provide
                  Angiometrx with prompt written notice of all material changes
                  in management or sales personnel responsible for the promotion
                  and sale of the Products in the Territory; f.) When
                  appropriate, assist Angiometrx in collecting clinical data
                  from designated clinical centers within the Territory; g.)
                  Maintain in accordance with Angiometrx's requirements
                  complete, accurate and current records on Product shipments so
                  that quarterly reports may be sent to Angiometrx indicating
                  location, by serial number or lot number, of all Products sold
                  to Distributor by Angiometrx; and h.) Assist Angiometrx in any
                  recall of Products sold in the Territory.

4. SURVIVING OBLIGATIONS.

         Upon the expiration or termination of this Agreement, all rights of
         Distributor under this Agreement shall immediately cease, and
         Angiometrx may appoint a new distributor(s) of the Products in the
         Territory. The following obligations of Distributor shall survive and
         continue after expiration or termination of this Agreement:

         a.) To offer to sell its inventory of the Products back to Angiometrx
         at the purchase price originally paid by Distributor, less any credits
         and allowances applied to Distributor's account for the Products.
         Unless such termination is the result of an Event of Default by
         Distributor as described in Section 1(b)(2), Angiometrx shall be
         obliged to repurchase such Products, provided they are in their
         original packaging, form and condition, subject to the terms of section
         2(e)(5).

         b.) To immediately return to Angiometrx all Product samples,
         information, literature and other documents supplied to Distributor by
         Angiometrx;

         c.) To continue to make payments owed to Angiometrx promptly when due;

         d.) To provide a final, current and accurate record of the location of
         all Product not returned to Angiometrx under section (a) above;

         e.) To cease trading in the Products and give prompt notice to all
         sub-distributors, agents and employees in the Territory of the
         cessation of Distributor's rights to distribute the Products in the
         Territory;

         f.) To continue to indemnify Angiometrx with respect to all matters to
         which indemnification by Distributor is covenanted herein;

         g.) To continue to keep information confidential and protect
         Angiometrx's Intellectual Property as provided under Section 8; and

         h.) To continue to observe any and all obligations of Distributor
         herein which are to survive expiration of this Agreement according to
         express terms of this Agreement.

5. ANGIOMETRX'S OBLIGATIONS.

         In addition to Angiometrx's other agreements herein, Angiometrx further
         agrees to:

         a.) Furnish to Distributor reasonable quantities of promotional
         materials and marketing literature as sales aids for the Products. All
         such promotional materials shall be and remain the exclusive property
         of Angiometrx;

         b.) Provide to Distributor in writing, or by oral or other
         presentation, information and training concerning the technical
         specifications of the Products; together with training necessary to
         allow Distributor personnel to effectively sell and service its
         customers;

         c.) Cooperate with Distributor in the planning of technical and
         educational seminars on the Products;


                                       53
<PAGE>

         d.) Respond to inquiries from Distributor regarding the Products, their
         use and application, the status of shipments on accepted purchase
         orders, new or improved versions of the Products and the like; and

         e.) Refrain from soliciting for employment by Angiometrx employees of
         Distributor during the term of this agreement and for one (1) year
         following the termination or expiration of this Agreement. This
         obligation shall survive the termination or expiration of this
         Agreement unless such termination results from an Event of Default by
         Distributor under this Agreement.

6. COMPLIANCE WITH LAW.

         a.) Angiometrx will comply with all pertinent statutes, regulations and
         rules governing the manufacture and sale of medical devices in the
         United States and all applicable requirements of the United States Food
         and Drug Administration.

         b.) Distributor shall be solely responsible for compliance in the
         Territory with all applicable local laws and regulations relating to
         distribution of the Products and the marketing and sale thereof by
         Distributor. Angiometrx and Distributor will cooperate where
         appropriate in order to assure compliance of both parties with such
         laws and regulations.



7. LIMITED WARRANTY AND LIMITATION OF REMEDIES. [Warranty attached as Exhibit F]

         a.)      The sole warranty given by Angiometrx to Distributor
                  respecting the Products shall be that contained in the
                  literature supplied by Angiometrx with the Products, which
                  warranty Angiometrx may change at any time in its sole
                  discretion, subject to 60 days notice to Distributor prior to
                  any such change. Angiometrx's liability will be limited to the
                  provisions of such warranty, and Distributor shall not make
                  any other representations or warranties respecting the
                  Products. SUCH WARRANTY IS EXCLUSIVE AND IS GIVEN IN LIEU OF
                  ALL OTHER WARRANTIES, REPRESENTATIONS, GUARANTEES AND
                  CONDITIONS, EXPRESSED OR IMPLIED, STATUTORY OR OTHERWISE
                  INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY,
                  DURABILITY AND FITNESS FOR PURPOSE (INCLUDING FITNESS FOR A
                  PARTICULAR PURPOSE) AND WARRANTIES ARISING FROM USAGE OF TRADE
                  OR COURSE OF DEALING. Any description of Products, whether in
                  writing or made orally by Angiometrx, specifications, samples,
                  models, bulletins, drawing, diagrams, or similar material used
                  in connection with the Products are for the sole purpose of
                  identifying the Products and shall not be construed as an
                  express warranty or representation. ANGIOMETRX AND DISTRIBUTOR
                  SPECIFICALLY EXCLUDE THE APPLICATION OF THE UNITED NATIONS
                  CONVENTION ON CONTRACTS FOR THE INTERNATIONAL SALE OF GOODS.

         b.)      DISTRIBUTOR'S EXCLUSIVE REMEDY FOR ANY BREACH OF THE WARRANTY
                  DESCRIBED IN SECTION 7.a.) WILL BE REPLACEMENT OF SUCH
                  PRODUCTS BY ANGIOMETRX OR, AT ANGIOMETRX'S ELECTION, REFUND OF
                  THE PURCHASE PRICE. ANGIOMETRX SHALL NOT BE SUBJECT TO AND
                  EXPRESSLY DISCLAIMS: (A) ANY OTHER OBLIGATIONS OR LIABILITIES
                  ARISING OUT OF BREACH OF CONTRACT OR OF WARRANTY, (B) ANY
                  OBLIGATIONS WHATSOEVER ARISING FROM TORT CLAIMS (INCLUDING
                  NEGLIGENCE AND STRICT LIABILITY) OR ARISING UNDER OTHER
                  THEORIES OF LAW WITH RESPECT TO PRODUCTS OR ANY UNDERTAKINGS,
                  ACTS OR OMISSIONS RELATING THERETO, AND C) ALL CONSEQUENTIAL,
                  INCIDENTAL, SPECIAL AND CONTINGENT DAMAGES WHATSOEVER, WITHOUT
                  LIMITING THE GENERALITY OF THE FOREGOING, ANGIOMETRX
                  SPECIFICALLY DISCLAIMS ANY LIABILITY FOR PROPERTY OR PERSONAL
                  INJURY DAMAGES, PENALTIES, SPECIAL OR PUNITIVE DAMAGES,
                  DAMAGES FOR LOST PROFITS OR REVENUES, OR ANY OTHER ECONOMIC
                  LOSS AND FOR CLAIMS OF DISTRIBUTOR'S CUSTOMERS OR ANY THIRD
                  PARTY FOR ANY SUCH DAMAGES. Distributor shall be liable to
                  Angiometrx for any Products damaged after title and risk of
                  loss is passed to Distributor, or for any Products to which
                  Distributor made changes in fabrication, assembly or
                  otherwise.

         c.)      Angiometrx shall hold Distributor harmless from any and all
                  claims, demands and liabilities (including product liability)
                  arising from or related to any claim, action or proceeding
                  made by a third party as a result of Angiometrx's activities
                  hereunder (subject to the limitations described in paragraph
                  7.a. and 7.b above) unless such liability arises from a
                  negligent act or omission of Distributor.

         d.)      Distributor shall not make any oral or written representations
                  that vary from the specifications, operating instructions or
                  representations given or made by Angiometrx to Distributor or
                  Distributor's employees with respect to the Products.

         e.)      Distributor shall defend and hold harmless Angiometrx and any
                  of its affiliates from and against any and all claims,
                  demands, actions, liabilities, damages, judgments, liens,
                  costs losses and expenses (including legal expense) which may
                  be suffered as a result of or in connection with the conduct
                  of the business of Distributor or any failure of Distributor
                  to perform and observe its obligations under this Agreement.

         f.)      Notwithstanding anything herein to the contrary, subject to
                  the consent of Manufacturer, such consent not to be
                  unreasonably withheld, Distributor is authorized to offer
                  extended warranty programs and to offer warranty coverage, at
                  its risk and expense, beyond the warranty coverage offered by
                  Manufacturer. Distributor shall be entitled to all of the
                  profits, if any, derived from said extended warranty programs.




                                       54
<PAGE>


8. CONFIDENTIALITY AND INTELLECTUAL PROPERTY.

         a.) Distributor acknowledges Angiometrx's exclusive right, title and
         interest in the Territory to Angiometrx's patents, trademarks, trade
         names, emblems, designs, models and methods of presentation relating to
         the Products (referred to as "Intellectual Property"). Distributor
         shall not do or cause to be done anything, which directly or indirectly
         challenges or impairs Angiometrx's rights to the Intellectual Property.

         b.) Except as expressly provided herein, this Agreement does not give
         Distributor any right, title, license, or interest to the Intellectual
         Property and Distributor will not describe or represent itself as
         having such rights.

         c.) Distributor may use Angiometrx's Intellectual Property only in
         connection with the promotion, marketing and sale of the Products.
         During the term of this Agreement, Distributor may refer to itself on
         its letterhead and in advertisements as the authorized distributor of
         the Products and put Angiometrx's company logo in promotional materials
         relating to the Products. In no event is Distributor granted the right
         to use Angiometrx's Intellectual Property in connection with other
         goods distributed by Distributor, or to use or adapt such Intellectual
         Property or any confusingly similar words or symbols as part of its
         commercial name.

         d) Distributor acknowledges that it will obtain confidential
         information from Angiometrx and that the disclosure of this information
         would inflict irreparable harm upon Angiometrx. Distributor agrees to
         maintain in confidence aII information it may receive under this
         Agreement concerning the Products or Angiometrx's business, and
         Distributor will not disclose or disseminate such information to others
         without the prior written consent of Angiometrx. Distributor
         specifically agrees: (1) not to disclose to any unauthorized person any
         information concerning the terms and conditions of this Agreement; (2)
         to take all reasonable steps to prevent unauthorized disclosure of
         confidential information by Distributor's sub-distributors, agents and
         employees; and (3) to safeguard and protect all confidential documents
         from theft, loss or perusal by unauthorized persons.

9. FORCE MAJEURE AND OTHER CONTINGENCIES.

         Neither Angiometrx nor Distributor shall have any liability to the
         other or any third party for any failure or delay in the performance of
         any obligation under this Agreement (except the obligation to make
         payments as and when due) if directly or indirectly caused by or
         resulting from force majeure beyond the reasonable control and without
         fault or negligence of the party claiming force majeure. The party
         claiming force majeure will give the other party written notice of the
         cause within fifteen (15) days after the occurrence, and will exercise
         reasonable diligence to remove the cause and resume performance. If
         Angiometrx is the affected party, it may equitably allocate production
         and delivery of affected Products among its customers and its
         distributors. If any performance is suspended or delayed because of
         force majeure, the period for performance will be correspondingly
         extended; provided however, if the performance is suspended or delayed
         for more than six (6) months the party not claiming force majeure may
         at any time after such six (6) month period, and while the performance
         remains suspended or delayed, terminate this Agreement by written
         notice to the other party as provided in Section 14 below.

10. EQUITABLE RELIEF.

         Distributor acknowledges and agrees that, in the event of a breach by
         Distributor of any of the provisions of Sections 1(d) (Conflicts of
         Interest) or 8(d) (Confidentiality) of this Agreement, Angiometrx's
         remedies at law will be inadequate and such breach may cause Angiometrx
         substantial and irreparable injury and damages. Distributor agrees that
         Angiometrx will be entitled to the remedies of injunction, specific
         performance and other equitable relief to prevent a breach of such
         provisions of this Agreement. The exercise by Angiometrx of its rights
         under this Section 10 shall not be construed as a waiver of any rights
         which Angiometrx may have for damages or otherwise in the event of a
         breach of the provisions of Sections 1(d) and 8(d), or any other
         provision of this Agreement.



                                       55
<PAGE>





11. NO LIABILITY FOR TERMINATION.

         No party terminating this Agreement in accordance with its terms shall,
         because of such termination, be liable to the other for compensation,
         reimbursement or damages on account of loss of profits on sales or
         estimated profits on anticipated sales or on account of expenditures,
         investments or commitments made in connection with the business or
         goodwill of the other party and neither party shall have such claim
         upon the expiration of this Agreement. Termination of this Agreement
         will not release either party from any debt owed to the other party
         prior to termination.

12. SETOFF.

         Angiometrx reserves the right to set off any amounts Distributor owes
         to Angiometrx against any amount Angiometrx owes to Distributor

13. SEVERABILITY.

         If any one or more of the provisions contained in this Agreement shall
         for any reason be held invalid, illegal, or the impossibility of
         enforcement in any respect, such invalidity, illegality, or the
         impossibility of enforcement shall not affect any other provision of
         this Agreement.

14. NOTICES.

         All notices or consents required by this Agreement shall be in writing
         in English. Notices shall be deemed delivered if: a) delivered in
         person, b) sent by certified mail, return receipt requested, correct
         postage prepaid, c) by telecopy, or d) by recognized international,
         commercial, overnight courier, to the address and/or telecopier number
         listed below, unless such address or telecopier number is changed by
         written notice hereunder:

         If to Angiometrx:

         Angiometrx
         107 - 1099 8th Avenue West
         Vancouver, BC Canada
         V6H 1C3

         Telecopy: (604) 742-3812

         Attention:  Mr. Alexei Marko,President
         Cc: Michael Varabioff, General Counsel

         If to Distributor:

         Possis Medical Inc.
         9055 Evergreen Boulevard NW
         Minneapolis, Minnesota 55433

         Telecopy:         763-780-7223

         Attention:  Robert G. Dutcher, Chairman, CEO and President
                     CC: Irving R. Colacci, Vice President and General Counsel
                     Shawn F. McCarrey, Vice President, Worldwide Sales

         Any notice or consent delivered (a) in person shall be deemed delivered
         when delivered and signed for by any person at the address above; (b)
         by certified mail, postage prepaid, return receipt requested, shall be
         deemed delivered on the seventh business day after the date deposited
         in the mail; (c) by telecopier transmission shall be deemed delivered
         on the date sent, if sent before 5:00 p.m. on a business day in the
         recipient's location, and in any event only when a transmission report
         is retained by the sender which indicates the telecopy has been duly
         received; and (d) by courier service shall be deemed delivered on the
         next business day after the date sent.


                                       56
<PAGE>





15. APPLICABLE LAW.

         a.) This Agreement shall be governed by the Province of British
         Columbia law, without regard to principles of choice of laws and the
         parties hereby submit to the jurisdiction of the Courts of British
         Columbia and agrees that service of process may be completed and shall
         be effective and binding upon the party served if mailed by certified
         mail, return receipt requested, postage prepaid and properly addressed
         to the party as set forth in Angiometrx's records.

         b.) Distributor represents and warrants to Angiometrx that each of the
         provisions of this Agreement is valid, binding and enforceable under
         the laws in existence in the Territory. Distributor agrees that upon
         request by Angiometrx, Distributor shall provide Angiometrx with an
         opinion of counsel to the foregoing effect.

16. ENTIRE AGREEMENT.

         This Agreement constitutes the entire understanding between the parties
         with respect to the subject matter hereof; no other representations or
         covenants have induced either party to enter into this Agreement.

17. CONSTRUCTION.

         The paragraph headings of this Agreement are for convenience of
         reference only and do not form a part of the terms of this Agreement.
         As used in this Agreement, the masculine, feminine or neuter pronoun
         shall include each the masculine, feminine and neuter genders. A
         reference to a person or entity shall mean a natural person, a trustee,
         a corporation, a partnership or any other form of legal entity. All
         references (including pronouns) in the singular or plural number shall
         be deemed to have been made, respectively, in the plural or singular
         number as well, as the context may require.

18. BENEFIT.

         This Agreement shall be binding on, and inure to the benefit of, the
         parties hereto and their respective heirs, executors, administrators,
         successors and permitted assigns. The Distributor may not assign this
         Agreement without the prior written consent of Angiometrx.

19. COUNTERPARTS.

         This Agreement may be executed in counterparts which when taken
         together shall constitute one agreement which is binding on all the
         parties, even though all the parties are not signatories to the same
         counterpart.

20. AMENDMENT AND MODIFICATION.

         This Agreement may be amended or modified, or any provision hereof may
         be waived, only by a written amendment or waiver executed by Angiometrx
         and Distributor.

21. SURVIVAL.

         All representations, warranties, covenants and agreements set forth in
         this Agreement will survive the execution and delivery of this
         Agreement and the consummation of the transaction contemplated hereby.

22. NO WAIVER.

         Waiver of any default shall not be considered a waiver of any other
         default or of the same default occurring subsequently. No delay or
         failure by any party to exercise any right or remedy shall be a waiver
         of such right or remedy, and no single or partial exercise of any right
         or remedy shall preclude the further exercise thereof, or the exercise
         at any time of any other right or remedy.

23. EXHIBITS.

         The Exhibits, which are attached and made a part hereof, are a part of
         this Agreement as if fully set forth herein. All references herein to
         sections, subsections, clauses and exhibits shall be deemed references
         to such parts of this Agreement, unless the context shall otherwise
         require.



                                       57
<PAGE>





24. THIRD PARTY BENEFICIARY.

         This Agreement is not intended as and shall not be construed to make
         any third party a beneficiary hereof. No creditor of Distributor shall
         have or receive any direct or indirect benefits hereunder and this
         Agreement may be enforced only by the parties hereto.

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year
first above written.

Angiometrx Inc.

                                 By:   /s/   Alexei Marko
                                       -------------------------
                                       Alexei Marko, President


Possis Medical, Inc.

                                 By:   /s/   Robert G. Dutcher
                                       ------------------------------------
                                       Robert G. Dutcher,
                                       Chairman, CEO and President



                                       58